Search Results - "Steckler, Thomas"

Refine Results
  1. 1
  2. 2
  3. 3

    Pharmacological treatment of PTSD – Established and new approaches by Steckler, Thomas, Risbrough, Victoria

    Published in Neuropharmacology (01-02-2012)
    “…A large proportion of humans will experience a traumatic event at least once in their lifetime, with up to 10% then going on to developing posttraumatic stress…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    Negative symptoms of schizophrenia: Clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment by Millan, Mark J, Fone, Kevin, Steckler, Thomas, Horan, William P

    Published in European neuropsychopharmacology (01-05-2014)
    “…Abstract Schizophrenia is a complex and multifactorial disorder generally diagnosed in young adults at the time of the first psychotic episode of delusions and…”
    Get full text
    Journal Article
  8. 8
  9. 9

    NMDA receptors, cognition and schizophrenia – Testing the validity of the NMDA receptor hypofunction hypothesis by Gilmour, Gary, Dix, Sophie, Fellini, Laetitia, Gastambide, Francois, Plath, Niels, Steckler, Thomas, Talpos, John, Tricklebank, Mark

    Published in Neuropharmacology (01-03-2012)
    “…Cognitive dysfunction is core to schizophrenia, and remains poorly treated by existing therapies. A prominent hypothesis suggests that many symptoms arise from…”
    Get full text
    Journal Article
  10. 10

    Metabolomic biosignature differentiates melancholic depressive patients from healthy controls by Liu, Yashu, Yieh, Lynn, Yang, Tao, Drinkenburg, Wilhelmus, Peeters, Pieter, Steckler, Thomas, Narayan, Vaibhav A, Wittenberg, Gayle, Ye, Jieping

    Published in BMC genomics (23-08-2016)
    “…Major depressive disorder (MDD) is a heterogeneous disease at the level of clinical symptoms, and this heterogeneity is likely reflected at the level of…”
    Get full text
    Journal Article
  11. 11

    Nicotine Improves Working Memory Span Capacity in Rats Following Sub-Chronic Ketamine Exposure by RUSHFORTH, Samantha L, STECKLER, Thomas, SHOAIB, Mohammed

    Published in Neuropsychopharmacology (01-12-2011)
    “…Ketamine, an NMDA-receptor antagonist, produces cognitive deficits in humans in a battery of tasks involving attention and memory. Nicotine can enhance various…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Corticotropin-releasing hormone receptor subtypes and emotion by Steckler, Thomas, Holsboer, Florian

    Published in Biological psychiatry (1969) (01-12-1999)
    “…Preclinical data indicate that corticotropin-releasing hormone (CRH) has anxiogenic properties and a dysregulation in CRH systems has been suggested to play a…”
    Get full text
    Journal Article
  14. 14

    The preclinical data forum network: A new ECNP initiative to improve data quality and robustness for (preclinical) neuroscience by Steckler, Thomas, Brose, Katja, Haas, Magali, Kas, Martien J, Koustova, Elena, Bespalov, Anton

    Published in European neuropsychopharmacology (01-10-2015)
    “…Abstract Current limitations impeding on data reproducibility are often poor statistical design, underpowered studies, lack of robust data, lack of…”
    Get full text
    Journal Article
  15. 15

    In vivo electroporation of the central nervous system: a non-viral approach for targeted gene delivery by De Vry, Jochen, Martínez-Martínez, Pilar, Losen, Mario, Temel, Yasin, Steckler, Thomas, Steinbusch, Harry W M, De Baets, Marc H, Prickaerts, Jos

    Published in Progress in neurobiology (01-11-2010)
    “…Electroporation is a widely used technique for enhancing the efficiency of DNA delivery into cells. Application of electric pulses after local injection of DNA…”
    Get full text
    Journal Article
  16. 16

    Blocking melanin-concentrating hormone MCH1 receptor affects rat sleep-wake architecture by AHNAOU, Abdellah, DRINKENBURG, Wilhelmus H. I. M, ADRIAAN BOUWKNECHT, J, ALCAZAR, Jesus, STECKLER, Thomas, DAUTZENBERG, Frank M

    Published in European journal of pharmacology (28-01-2008)
    “…Melanin-concentrating hormone (MCH) is a hypothalamic peptide that centrally regulates food intake, energy balance and emotion. Interestingly, MCH and…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Modulation of group II metabotropic glutamate receptor (mGlu 2) elicits common changes in rat and mice sleep–wake architecture by Ahnaou, Abdellah, Dautzenberg, Frank M., Geys, Helena, Imogai, Hassan, Gibelin, Antoine, Moechars, Dieder, Steckler, Thomas, Drinkenburg, Wilhelmus H.I.M.

    Published in European journal of pharmacology (28-01-2009)
    “…Compiling pharmacological evidence implicates metabotropic glutamate mGlu 2 receptors in the regulation of emotional states and suggests positive modulators as…”
    Get full text
    Journal Article
  19. 19

    Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1 by Wurst, Wolfgang, Timpl, Peter, Spanagel, Rainer, Sillaber, Inge, Kresse, Adelheid, Reul, Johannes M. H. M, Stalla, Günter K, Blanquet, Veronique, Steckler, Thomas, Holsboer, Florian

    Published in Nature genetics (01-06-1998)
    “…Corticotropin-releasing hormone (CRH) is a potent mediator of endocrine, autonomic, behavioural and immune responses to stress, and has been implicated in the…”
    Get full text
    Journal Article
  20. 20

    IMPA1 is essential for embryonic development and lithium-like pilocarpine sensitivity by Cryns, Kim, Shamir, Alon, Van Acker, Nathalie, Levi, Itzhak, Daneels, Guy, Goris, Ilse, Bouwknecht, J Adriaan, Andries, Luc, Kass, Stefan, Agam, Galila, Belmaker, Haim, Bersudsky, Yuly, Steckler, Thomas, Moechars, Dieder

    Published in Neuropsychopharmacology (New York, N.Y.) (01-02-2008)
    “…Lithium has been the standard pharmacological treatment for bipolar disorder over the last 50 years; however, the molecular targets through which lithium…”
    Get full text
    Journal Article